Literature DB >> 23755843

Coffee consumption delays the hepatitis and suppresses the inflammation related gene expression in the Long-Evans Cinnamon rat.

Masafumi Katayama1, Kenichiro Donai1, Hiroyuki Sakakibara2, Yukiko Ohtomo1, Makoto Miyagawa3, Kengo Kuroda1, Hiroko Kodama4, Kazufumi Suzuki5, Noriyuki Kasai6, Katsuhiko Nishimori1, Takafumi Uchida1, Kouichi Watanabe1, Hisashi Aso1, Emiko Isogai1, Hideko Sone7, Tomokazu Fukuda8.   

Abstract

BACKGROUND AND AIMS: Large-scale epidemiological studies have shown that drinking more than two cups of coffee per day reduces the risks of hepatitis and liver cancer. However, the heterogeneity of the human genome requires studies of experimental animal models with defined genetic backgrounds to evaluate the coffee effects on liver diseases. We evaluated the efficacy of coffee consumption with one of experimental animal models for human disease.
METHOD: We used the Long Evans Cinnamon (LEC) rat, which onsets severe hepatitis and high incidence of liver cancer, due to the accumulation of copper and iron in livers caused by the genetic mutation in Atp7B gene, and leading to the continuous oxidative stress. We determined the expression of inflammation related genes, and amounts of copper and iron in livers, and incidence of the pre-neoplastic foci in the liver tissue of LEC rats.
RESULTS: Coffee administration for 25 weeks delayed the occurrence of hepatitis by two weeks, significantly improved survival, reduced the expression of inflammatory cytokines, and reduced the incidence of small pre-neoplastic liver foci in LEC rats. There was no significant difference in the accumulation of copper and iron in livers, indicating that coffee administration does not affect to the metabolism of these metals. These findings indicate that drinking coffee potentially prevents hepatitis and liver carcinogenesis through its anti-inflammatory effects.
CONCLUSION: This study showed the efficacy of coffee in the prevention of hepatitis and liver carcinogenesis in the LEC model.
Copyright © 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Coffee; Cytokine; Experimental animal model; Hepatitis; Liver cancer; Pre-neoplastic foci

Mesh:

Substances:

Year:  2013        PMID: 23755843     DOI: 10.1016/j.clnu.2013.05.006

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  8 in total

1.  Coffee but not green tea consumption is associated with prevalence and severity of hepatic steatosis: the impact on leptin level.

Authors:  T Imatoh; S Kamimura; M Miyazaki
Journal:  Eur J Clin Nutr       Date:  2015-03-25       Impact factor: 4.016

Review 2.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

3.  Aqueous Date Flesh or Pits Extract Attenuates Liver Fibrosis via Suppression of Hepatic Stellate Cell Activation and Reduction of Inflammatory Cytokines, Transforming Growth Factor- β 1 and Angiogenic Markers in Carbon Tetrachloride-Intoxicated Rats.

Authors:  Nouf M Al-Rasheed; Hala A Attia; Raeesa A Mohamad; Nawal M Al-Rasheed; Maha A Al-Amin; Asma Al-Onazi
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-06       Impact factor: 2.629

Review 4.  Molecular Bases Underlying the Hepatoprotective Effects of Coffee.

Authors:  Federico Salomone; Fabio Galvano; Giovanni Li Volti
Journal:  Nutrients       Date:  2017-01-23       Impact factor: 5.717

5.  Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient survey.

Authors:  Christiane Barthel; Sandra Wiegand; Sylvie Scharl; Michael Scharl; Pascal Frei; Stephan R Vavricka; Michael Fried; Michael Christian Sulz; Nico Wiegand; Gerhard Rogler; Luc Biedermann
Journal:  Nutr J       Date:  2015-08-12       Impact factor: 3.271

6.  The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.

Authors:  Krasimira Aleksandrova; Christina Bamia; Dagmar Drogan; Pagona Lagiou; Antonia Trichopoulou; Mazda Jenab; Veronika Fedirko; Isabelle Romieu; H Bas Bueno-de-Mesquita; Tobias Pischon; Kostas Tsilidis; Kim Overvad; Anne Tjønneland; Marie-Christine Bouton-Ruault; Laure Dossus; Antoine Racine; Rudolf Kaaks; Tilman Kühn; Christos Tsironis; Eleni-Maria Papatesta; George Saitakis; Domenico Palli; Salvatore Panico; Sara Grioni; Rosario Tumino; Paolo Vineis; Petra H Peeters; Elisabete Weiderpass; Marko Lukic; Tonje Braaten; J Ramón Quirós; Leila Luján-Barroso; María-José Sánchez; Maria-Dolores Chilarque; Eva Ardanas; Miren Dorronsoro; Lena Maria Nilsson; Malin Sund; Peter Wallström; Bodil Ohlsson; Kathryn E Bradbury; Kay-Tee Khaw; Nick Wareham; Magdalena Stepien; Talita Duarte-Salles; Nada Assi; Neil Murphy; Marc J Gunter; Elio Riboli; Heiner Boeing; Dimitrios Trichopoulos
Journal:  Am J Clin Nutr       Date:  2015-11-11       Impact factor: 7.045

7.  Caffeine reduces hepatic lipid accumulation through regulation of lipogenesis and ER stress in zebrafish larvae.

Authors:  Xinchun Zheng; Wencong Dai; Xiaohui Chen; Kunyuan Wang; Wenqing Zhang; Li Liu; Jinlin Hou
Journal:  J Biomed Sci       Date:  2015-11-17       Impact factor: 8.410

8.  Effects of Coffee Extracts with Different Roasting Degrees on Antioxidant and Anti-Inflammatory Systems in Mice.

Authors:  Sukyoung Choi; Soohan Jung; Kwang Suk Ko
Journal:  Nutrients       Date:  2018-03-16       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.